- Capital Cube•27 days ago
Categories: Yahoo Finance Click here to see latest analysis Bayer AG reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Bayer AG – Novartis AG, Eli Lilly and Company, Roche Holding AG, Merck & Co., Inc. and GlaxoSmithKline plc (NOVN-CH, LLY-CH, RO-CH, MRK-FR and GSK-GB) that have ... Read more (Read more...)
- MarketWatch•2 months ago
Monsanto Co. reported fiscal third-quarter earnings that declined to $717 million, or $1.63 a share, from $1.14 billion, or $2.39 a share, in the same period a year ago. Excluding non-recurring items, ...
- TheStreet.com•2 months ago
The French drugmaker is reportedly thinking about including a CVR in its $9.3 billion bid for Medivation, but the move is unlikely to be enough to entice the target's shareholders.
BAY NATIONAL CORP (BAYN)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|